Published in Proc Natl Acad Sci U S A on June 01, 1992
Stereotyped and specific gene expression programs in human innate immune responses to bacteria. Proc Natl Acad Sci U S A (2002) 3.85
The adenylate cyclase toxin of Bordetella pertussis binds to target cells via the alpha(M)beta(2) integrin (CD11b/CD18). J Exp Med (2001) 2.12
Probing the function of Bordetella bronchiseptica adenylate cyclase toxin by manipulating host immunity. Infect Immun (1999) 1.76
Pertussis toxin and adenylate cyclase toxin: key virulence factors of Bordetella pertussis and cell biology tools. Future Microbiol (2010) 1.30
Adenylate cyclase toxin from Bordetella pertussis synergizes with lipopolysaccharide to promote innate interleukin-10 production and enhances the induction of Th2 and regulatory T cells. Infect Immun (2004) 1.25
Pore-forming and enzymatic activities of Bordetella pertussis adenylate cyclase toxin synergize in promoting lysis of monocytes. Infect Immun (2006) 1.25
CyaC-mediated activation is important not only for toxic but also for protective activities of Bordetella pertussis adenylate cyclase-hemolysin. Infect Immun (1993) 1.22
Cell-invasive activity of epitope-tagged adenylate cyclase of Bordetella pertussis allows in vitro presentation of a foreign epitope to CD8+ cytotoxic T cells. Infect Immun (1995) 1.17
Pertussis toxin and adenylate cyclase toxin provide a one-two punch for establishment of Bordetella pertussis infection of the respiratory tract. Infect Immun (2005) 1.16
The C-terminal domain is essential for protective activity of the Bordetella pertussis adenylate cyclase-hemolysin. Infect Immun (1995) 0.89
Bordetella pertussis infection of primary human monocytes alters HLA-DR expression. Infect Immun (2004) 0.87
Suppression of platelet aggregation by Bordetella pertussis adenylate cyclase toxin. Infect Immun (1999) 0.78
Characterization of a hemolysin gene ytjA from Bacillus subtilis. Curr Microbiol (2009) 0.78
Stimulation of Bordetella pertussis adenylate cyclase toxin intoxication by its hemolysin domain. Infect Immun (2000) 0.76
A novel sensor kinase is required for Bordetella bronchiseptica to colonize the lower respiratory tract. Infect Immun (2011) 0.76
cAMP-elevating capacity of the adenylate cyclase toxin-hemolysin is sufficient for lung infection but not for full virulence of Bordetella pertussis. Infect Immun (2017) 0.76
Adenylate cyclase toxin (ACT) from Bordetella hinzii: characterization and differences from ACT of Bordetella pertussis. J Bacteriol (2005) 0.75
Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol (1975) 503.08
A highly sensitive adenylate cyclase assay. Anal Biochem (1974) 20.13
A simple chemically defined medium for the production of phase I Bordetella pertussis. J Gen Microbiol (1970) 8.89
Tn5-induced mutations affecting virulence factors of Bordetella pertussis. Infect Immun (1983) 8.49
Polarity of Tn5 insertion mutations in Escherichia coli. J Bacteriol (1980) 7.55
Pertussis toxin gene: nucleotide sequence and genetic organization. Science (1986) 6.02
Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence. Proc Natl Acad Sci U S A (1989) 4.87
Secretion of cyclolysin, the calmodulin-sensitive adenylate cyclase-haemolysin bifunctional protein of Bordetella pertussis. EMBO J (1988) 4.75
The calmodulin-sensitive adenylate cyclase of Bordetella pertussis: cloning and expression in Escherichia coli. Mol Microbiol (1988) 4.15
Phagocyte impotence caused by an invasive bacterial adenylate cyclase. Science (1982) 4.10
The construction of a cloning vector designed for gene replacement in Bordetella pertussis. Gene (1986) 4.01
Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis. J Infect Dis (1984) 3.48
Purification and characterization of a hemolysin produced by Vibrio cholerae biotype El Tor: another toxic substance produced by cholera vibrios. Infect Immun (1979) 2.99
Mutants of pertussis toxin suitable for vaccine development. Science (1989) 2.89
Inhibitors of receptor-mediated endocytosis block the entry of Bacillus anthracis adenylate cyclase toxin but not that of Bordetella pertussis adenylate cyclase toxin. Infect Immun (1988) 2.69
Bordetella pertussis adenylate cyclase toxin and hemolytic activities require a second gene, cyaC, for activation. J Bacteriol (1991) 1.90
Adenylate cyclase toxin is critical for colonization and pertussis toxin is critical for lethal infection by Bordetella pertussis in infant mice. Infect Immun (1990) 1.87
Bordetella pertussis invasive adenylate cyclase. Partial resolution and properties of its cellular penetration. J Biol Chem (1985) 1.78
Pertussis vaccine: present status and future prospects. Vaccine (1985) 1.63
Secondary analyses of the efficacy of two acellular pertussis vaccines evaluated in a Swedish phase III trial. Vaccine (1990) 1.43
Deletions affecting hemolytic and toxin activities of Bordetella pertussis adenylate cyclase. Infect Immun (1990) 1.41
Bordetella adenylate cyclase: a genus specific protective antigen and virulence factor. Dev Biol Stand (1985) 1.32
Pertussis toxin is required for pertussis vaccine encephalopathy. Proc Natl Acad Sci U S A (1985) 1.31
Identification of residues essential for catalysis and binding of calmodulin in Bordetella pertussis adenylate cyclase by site-directed mutagenesis. EMBO J (1989) 1.27
Hemolytic activity of adenylate cyclase toxin from Bordetella pertussis. FEBS Lett (1991) 1.15
Calmodulin inhibits entry of Bordetella pertussis adenylate cyclase into animal cells. Biochemistry (1985) 1.14
Bordetella adenylate cyclase is a virulence associated factor and an immunoprotective antigen. Microb Pathog (1989) 1.12
Human serologic response to envelope-associated proteins and adenylate cyclase toxin of Bordetella pertussis. J Infect Dis (1991) 1.04
Site-directed mutagenesis of lysine 58 in a putative ATP-binding domain of the calmodulin-sensitive adenylate cyclase from Bordetella pertussis abolishes catalytic activity. Biochemistry (1989) 0.86
Whooping cough vaccine research revs up. Science (1985) 0.81
Evidence that the adenylate cyclase secreted from Bordetella pertussis does not enter animal cells by receptor-mediated endocytosis. J Cell Physiol (1990) 0.79
Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N Engl J Med (1994) 7.98
Chromatin cleavage in apoptosis: association with condensed chromatin morphology and dependence on macromolecular synthesis. J Pathol (1984) 6.67
A rapid chemical assay for gentamicin. N Engl J Med (1972) 6.36
Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group. N Engl J Med (1999) 6.23
Haemophilus influenzae meningitis in infant rats after intranasal inoculation. J Infect Dis (1974) 4.94
Longitudinal assessment of Pseudomonas aeruginosa in young children with cystic fibrosis. J Infect Dis (2000) 4.93
Production of Haemophilus influenzae b meningitis in infant rats by intraperitoneal inoculation. Infect Immun (1973) 4.80
Polymyxin and related peptide antibiotics. Annu Rev Biochem (1977) 4.53
Characterization of non-beta-lactamase-mediated ampicillin resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1984) 4.25
Photoactivated gamma-secretase inhibitors directed to the active site covalently label presenilin 1. Nature (2000) 4.12
2-Aryl tryptamines: selective high-affinity antagonists for the h5-HT2A receptor. Bioorg Med Chem Lett (2000) 4.03
Chronic Lyme borreliosis in the laboratory mouse. Am J Pathol (1993) 3.82
Stimulation of cAMP response element (CRE)-mediated transcription during contextual learning. Nat Neurosci (1998) 3.33
Improved enzymatic assay of chloramphenicol. Clin Chem (1978) 3.31
Ca2+/calmodulin binds to and modulates P/Q-type calcium channels. Nature (1999) 3.24
Cross talk between ERK and PKA is required for Ca2+ stimulation of CREB-dependent transcription and ERK nuclear translocation. Neuron (1998) 3.08
Calcium-stimulated adenylyl cyclase activity is critical for hippocampus-dependent long-term memory and late phase LTP. Neuron (1999) 2.86
Hemophilus influenzae type B susceptibility to 17 antibiotics. J Pediatr (1975) 2.74
Disruption of the type III adenylyl cyclase gene leads to peripheral and behavioral anosmia in transgenic mice. Neuron (2000) 2.73
Lyme borreliosis in genetically resistant and susceptible mice with severe combined immunodeficiency. Am J Trop Med Hyg (1992) 2.71
Induction of CRE-mediated gene expression by stimuli that generate long-lasting LTP in area CA1 of the hippocampus. Neuron (1996) 2.47
Gentamicin:adenine mononucleotide transferase: partial purification, characterization, and use in the clinical quantitation of gentamicin. J Infect Dis (1974) 2.45
Rapid detection of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1981) 2.41
Failure to detect ampicillin-resistant, non-beta-lactamase-producing Haemophilus influenzae by standard disk susceptibility testing. Antimicrob Agents Chemother (1986) 2.38
L-685,458, an aspartyl protease transition state mimic, is a potent inhibitor of amyloid beta-protein precursor gamma-secretase activity. Biochemistry (2000) 2.36
Is the acetylcholine receptor a rabies virus receptor? Science (1982) 2.30
Relative penicillin G resistance in Neisseria meningitidis and reduced affinity of penicillin-binding protein 3. Antimicrob Agents Chemother (1988) 2.28
Light and circadian rhythmicity regulate MAP kinase activation in the suprachiasmatic nuclei. Nat Neurosci (1998) 2.20
Making new connections: role of ERK/MAP kinase signaling in neuronal plasticity. Neuron (1999) 2.17
Nonspecific proliferative responses of murine lymphocytes to Borrelia burgdorferi antigens. J Infect Dis (1992) 2.11
Characterization of chloramphenicol-resistant Haemophilus influenzae. Antimicrob Agents Chemother (1980) 2.07
Studies of the aetiology of neonatal hepatitis and biliary atresia. Arch Dis Child (1977) 2.04
Isolation and assay of rabies serogroup viruses in CER cells. Intervirology (1977) 2.03
The role of encapsulation and host age in the clearance of Haemophilus influenzae bacteremia. J Infect Dis (1977) 2.01
Characterization of Haemophilus influenzae type b fimbriae. Infect Immun (1984) 2.00
Antibiotics and invasive Haemophilus influenzae. N Engl J Med (1976) 2.00
Selective media for the quantitation of bacteria in cystic fibrosis sputum. J Med Microbiol (1984) 1.95
Altered behavior and long-term potentiation in type I adenylyl cyclase mutant mice. Proc Natl Acad Sci U S A (1995) 1.94
The paradox of Hemophilus infuenzae type B bacteremia in the presence of serum bactericidal activity. J Clin Invest (1976) 1.94
Sepsis and congenital asplenia. J Pediatr (1977) 1.93
T-cell alpha beta + and gamma delta + deficient mice display abnormal but distinct phenotypes toward a natural, widespread infection of the intestinal epithelium. Proc Natl Acad Sci U S A (1996) 1.92
Constitutive μ-opioid receptor activity leads to long-term endogenous analgesia and dependence. Science (2013) 1.91
In vitro antibacterial activity of fluorinated analogs of chloramphenicol and thiamphenicol. Antimicrob Agents Chemother (1981) 1.87
Circadian regulation of cAMP response element-mediated gene expression in the suprachiasmatic nuclei. J Biol Chem (1999) 1.85
Calcium-induced exposure of a hydrophobic surface on calmodulin. Biochemistry (1980) 1.85
Aminoglycoside penetration, inactivation, and efficacy in cystic fibrosis sputum. Am Rev Respir Dis (1985) 1.85
Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients. Am Rev Respir Dis (1991) 1.84
Clinical staging in Reye syndrome. Am J Dis Child (1974) 1.84
A permeability barrier as a mechanism of chloramphenicol resistance in Haemophilus influenzae. Antimicrob Agents Chemother (1985) 1.84
Isolation of field rabies virus strains in CER and murine neuroblastoma cell cultures. Intervirology (1978) 1.81
Effect of chronic intermittent administration of inhaled tobramycin on respiratory microbial flora in patients with cystic fibrosis. J Infect Dis (1999) 1.79
Lipid peroxidation by human blood phagocytes. J Clin Invest (1974) 1.79
The sequence of the cyo operon indicates substantial structural similarities between the cytochrome o ubiquinol oxidase of Escherichia coli and the aa3-type family of cytochrome c oxidases. J Biol Chem (1990) 1.78
Riboflavin and mouse hepatic cell structure and function. II. Division of mitochondria during recovery from simple deficiency. J Cell Biol (1969) 1.74
A virulent nonencapsulated Haemophilus influenzae. J Infect Dis (1996) 1.73
A first-generation whole genome-radiation hybrid map spanning the mouse genome. Genome Res (1997) 1.73
Use of fluoroquinolones in pediatrics: consensus report of an International Society of Chemotherapy commission. Pediatr Infect Dis J (1995) 1.70
Detection of relatively penicillin G-resistant Neisseria meningitidis by disk susceptibility testing. Antimicrob Agents Chemother (1987) 1.67
Comparative virulence of Haemophilus influenzae with a type b or type d capsule. Infect Immun (1981) 1.66
Role of immunity in the clearance of bacteremia due to Haemophilus influenzae. J Infect Dis (1978) 1.65
Altered stress-induced anxiety in adenylyl cyclase type VIII-deficient mice. J Neurosci (2000) 1.65
Phosphorylation and inhibition of olfactory adenylyl cyclase by CaM kinase II in Neurons: a mechanism for attenuation of olfactory signals. Neuron (1998) 1.63
Increasing incidence of ampicillin resistance in Hemophilus influenzae. J Pediatr (1978) 1.63
SRF-dependent gene expression is required for PI3-kinase-regulated cell proliferation. EMBO J (2000) 1.62
Disruption of the Escherichia coli outer membrane permeability barrier by immobilized polymyxin B. J Antibiot (Tokyo) (1977) 1.62
Effect of inoculum size on the susceptibility of Haemophilus influenzae b to beta-lactam antibiotics. Antimicrob Agents Chemother (1979) 1.60
Urogenital, maternal and neonatal isolates of Haemophilus influenzae: identification of unusually virulent serologically non-typable clone families and evidence for a new Haemophilus species. J Gen Microbiol (1990) 1.59
Disposition of drugs in cystic fibrosis. III. Acetaminophen. Clin Pharmacol Ther (1991) 1.59
Pigment gallstones form as a composite of bacterial microcolonies and pigment solids. Ann Surg (1987) 1.55
Complex formation between bacitracin peptides and isoprenyl pyrophosphates. The specificity of lipid-peptide interactions. J Biol Chem (1973) 1.51
Host cell receptors for two strains of Sindbis virus. Arch Virol (1980) 1.51
In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae. Antimicrob Agents Chemother (1989) 1.49
Characterization of mouse parvovirus infection by in situ hybridization. J Virol (1995) 1.49
Diagnosis of Wilson's disease: an experience over three decades. Gut (2000) 1.46
A call for health policy education in the medical school curriculum. JAMA (1995) 1.46
Psychiatric disorders in the first-degree relatives of probands with bulimia nervosa. Am J Psychiatry (1989) 1.46
Resolution of adenylate cyclase sensitive and insensitive to Ca2+ and calcium-dependent regulatory protein (CDR) by CDR-sepharose affinity chromatography. Proc Natl Acad Sci U S A (1979) 1.46
Capacitative Ca2+ entry is involved in cAMP synthesis in mouse parotid acini. Am J Physiol (1998) 1.45
Inhibition of Escherichia coli growth and respiration by polymyxin B covalently attached to agarose beads. Biochemistry (1977) 1.45
Suppression of airway inflammation by a natural acute infection of the intestinal epithelium. Mucosal Immunol (2008) 1.44
Barbiturate protection in cerebral hypoxia. Anesthesiology (1977) 1.44
Type I adenylyl cyclase mutant mice have impaired mossy fiber long-term potentiation. J Neurosci (1998) 1.43
Effect of misoprostol on fat malabsorption in cystic fibrosis. Arch Dis Child (1988) 1.41
Pathogenesis of infection with a virulent allotropic variant of minute virus of mice and regulation by host genotype. Lab Invest (1991) 1.41
Characterization of the calmodulin binding domain of neuromodulin. Functional significance of serine 41 and phenylalanine 42. J Biol Chem (1991) 1.41
Regulation of calmodulin binding to P-57. A neurospecific calmodulin binding protein. J Biol Chem (1987) 1.40
Group A streptococcal infections of the skin and pharynx (second of two parts). N Engl J Med (1977) 1.39
Identification and characterization of the calmodulin-binding domain of neuromodulin, a neurospecific calmodulin-binding protein. J Biol Chem (1988) 1.39
Hippocampal neurotoxicity of Delta9-tetrahydrocannabinol. J Neurosci (1998) 1.39
Angiographic and clinical follow-up of percutaneous revascularization for transplant coronary artery disease. J Invasive Cardiol (2000) 1.39
Pharmacokinetics of gentamicin in children and adults. J Infect Dis (1975) 1.39
Evaluation of a rapid beta-lactamase test for detecting ampicillin-resistant strains of Hemophilus influenzae type b. Pediatrics (1976) 1.39
Laboratory animal medicine in a time of crisis. Comp Med (2001) 1.39
Effect of chloramphenicol administration in drinking water on predictable steady-state serum concentrations of the drug in mice. Comp Med (2000) 1.39
College of American Pathologists and American Society for Reproductive Medicine accreditation of assisted reproductive technology (ART) laboratories is associated with a decrease in take home baby rates of reporting ART laboratories. Fertil Steril (2000) 1.39
Cerebral blood flow and metabolism: effects of anesthetic drugs and techniques. Anesthesiology (1972) 1.39
The cellular and molecular pathogenesis of coronaviruses. Lab Anim Sci (1993) 1.37
Age at primary infection with Salmonella enterica serovar Typhimurium in the chicken influences persistence of infection and subsequent immunity to re-challenge. Vet Immunol Immunopathol (2004) 1.35
Mouse parvovirus infection potentiates rejection of tumor allografts and modulates T cell effector functions. Transplantation (1996) 1.34
CRE-mediated gene transcription in neocortical neuronal plasticity during the developmental critical period. Neuron (1999) 1.34